SCHEMBL13615816

SCHEMBL13615816

CC(C)(C)c1ccc(N(c2ccc(-c3c4ccc(N(c5ccc(C(C)(C)C)cc5)c5ccc(C(C)(C)C)cc5)cc4c(-c4ccc(N(c5ccc(C(C)(C)C)cc5)c5ccc(C(C)(C)C)cc5)cc4)c4ccc(N(c5ccc(C(C)(C)C)cc5)c5ccc(C(C)(C)C)cc5)cc34)cc2)c2ccc(C(C)(C)C)cc2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 5/20 0.36
HTR1D P28221 1/20 0.33
ADRA1A P35348 1/20 0.33
NISCH Q9Y2I1 1/20 0.33
TSHR P16473 1/20 0.33
XDH P47989 1/20 0.33
TP53 P04637 2/20 0.33
MITF O75030 1/20 0.33
ALDH1A1 P00352 1/20 0.33
KMT2A Q03164 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
LMNA P02545 1/20 0.32
TYR P14679 1/20 0.32
PTGES O14684 1/20 0.32
ALOX5 P09917 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
GSK3B P49841 1/20 0.31
MAPT P10636 1/20 0.31
GPR84 Q9NQS5 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12928329 0.94 TP53 (0.37) KIF11TP53ALDH1A1KMT2ANPC1
SCHEMBL13615646 0.94 TP53 (0.37) KIF11TP53ALDH1A1KMT2ANPC1
SCHEMBL13615686 0.94 TP53 (0.37) KIF11TP53ALDH1A1KMT2ANPC1
SCHEMBL10304792 0.92 PTGES (0.38) KIF11TP53ALDH1A1KMT2ARAB9A
SCHEMBL13658873 0.91 KIF11 (0.49) KIF11HTR1DADRA1ANISCHTSHR
SCHEMBL12770708 0.91 PTGES (0.41) KIF11TP53ALDH1A1KMT2ARAB9A
SCHEMBL10304794 0.91 PTGES (0.37) KIF11TP53ALDH1A1KMT2ARAB9A
SCHEMBL13615656 0.89 TSHR (0.41) KIF11TSHRTP53ALDH1A1KMT2A
SCHEMBL13615665 0.87 KIF11 (0.40) KIF11TSHRTP53ALDH1A1KMT2A
SCHEMBL13615706 0.87 PTGES (0.39) KIF11TP53PTGESALOX5SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090273277-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2009-11-05 US disclosed
US-20090273277-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2009-11-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090273277-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OCIAD1, ORMDL3, CHRM2 KIF11 3191/4885HTR1D 871/4885ADRA1A 2467/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.